These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 28948650)

  • 21. Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis.
    Feng X; Szulzewsky F; Yerevanian A; Chen Z; Heinzmann D; Rasmussen RD; Alvarez-Garcia V; Kim Y; Wang B; Tamagno I; Zhou H; Li X; Kettenmann H; Ransohoff RM; Hambardzumyan D
    Oncotarget; 2015 Jun; 6(17):15077-94. PubMed ID: 25987130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myeloid cells expressing high level of CD45 are associated with a distinct activated phenotype in glioma.
    Brandenburg S; Turkowski K; Mueller A; Radev YT; Seidlitz S; Vajkoczy P
    Immunol Res; 2017 Jun; 65(3):757-768. PubMed ID: 28367602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CXCR4 increases in-vivo glioma perivascular invasion, and reduces radiation induced apoptosis: A genetic knockdown study.
    Yadav VN; Zamler D; Baker GJ; Kadiyala P; Erdreich-Epstein A; DeCarvalho AC; Mikkelsen T; Castro MG; Lowenstein PR
    Oncotarget; 2016 Dec; 7(50):83701-83719. PubMed ID: 27863376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival.
    Kloepper J; Riedemann L; Amoozgar Z; Seano G; Susek K; Yu V; Dalvie N; Amelung RL; Datta M; Song JW; Askoxylakis V; Taylor JW; Lu-Emerson C; Batista A; Kirkpatrick ND; Jung K; Snuderl M; Muzikansky A; Stubenrauch KG; Krieter O; Wakimoto H; Xu L; Munn LL; Duda DG; Fukumura D; Batchelor TT; Jain RK
    Proc Natl Acad Sci U S A; 2016 Apr; 113(16):4476-81. PubMed ID: 27044098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting c-Myc on cell growth and vascular endothelial growth factor expression in IN500 glioblastoma cells.
    Hu YH; Kong SQ; Kong HB; Wu JL; Chen Z
    Chin Med J (Engl); 2012 Jun; 125(11):2025-31. PubMed ID: 22884072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target.
    Wei J; Marisetty A; Schrand B; Gabrusiewicz K; Hashimoto Y; Ott M; Grami Z; Kong LY; Ling X; Caruso H; Zhou S; Wang YA; Fuller GN; Huse J; Gilboa E; Kang N; Huang X; Verhaak R; Li S; Heimberger AB
    J Clin Invest; 2019 Jan; 129(1):137-149. PubMed ID: 30307407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phytosomal curcumin causes natural killer cell-dependent repolarization of glioblastoma (GBM) tumor-associated microglia/macrophages and elimination of GBM and GBM stem cells.
    Mukherjee S; Fried A; Hussaini R; White R; Baidoo J; Yalamanchi S; Banerjee P
    J Exp Clin Cancer Res; 2018 Jul; 37(1):168. PubMed ID: 30041669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular endothelial growth factor receptor 1 in glioblastoma‑associated microglia/macrophages.
    Lisi L; Pia Ciotti GM; Chiavari M; Ruffini F; Lacal PM; Graziani G; Navarra P
    Oncol Rep; 2020 Jun; 43(6):2083-2092. PubMed ID: 32236632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-383 inhibits proliferation, migration and angiogenesis of glioma-exposed endothelial cells in vitro via VEGF-mediated FAK and Src signaling pathways.
    Zhao LN; Wang P; Liu YH; Cai H; Ma J; Liu LB; Xi Z; Li ZQ; Liu XB; Xue YX
    Cell Signal; 2017 Jan; 30():142-153. PubMed ID: 27693218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salinomycin exhibits anti-angiogenic activity against human glioma in vitro and in vivo by suppressing the VEGF-VEGFR2-AKT/FAK signaling axis.
    Bi YL; Mi PY; Zhao SJ; Pan HM; Li HJ; Liu F; Shao LR; Zhang HF; Zhang P; Jiang SL
    Int J Mol Med; 2017 May; 39(5):1255-1261. PubMed ID: 28358414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SDF-1 Blockade Enhances Anti-VEGF Therapy of Glioblastoma and Can Be Monitored by MRI.
    Deng L; Stafford JH; Liu SC; Chernikova SB; Merchant M; Recht L; Martin Brown J
    Neoplasia; 2017 Jan; 19(1):1-7. PubMed ID: 27940247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment.
    Li TF; Li K; Wang C; Liu X; Wen Y; Xu YH; Zhang Q; Zhao QY; Shao M; Li YZ; Han M; Komatsu N; Zhao L; Chen X
    J Control Release; 2017 Dec; 268():128-146. PubMed ID: 29051064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SDF-1/CXCR4 contributes to the activation of tip cells and microglia in retinal angiogenesis.
    Unoki N; Murakami T; Nishijima K; Ogino K; van Rooijen N; Yoshimura N
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3362-71. PubMed ID: 20181837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell Biology.
    Tate CM; Mc Entire J; Pallini R; Vakana E; Wyss L; Blosser W; Ricci-Vitiani L; D'Alessandris QG; Morgante L; Giannetti S; Larocca LM; Todaro M; Benfante A; Colorito ML; Stassi G; De Maria R; Rowlinson S; Stancato L
    PLoS One; 2015; 10(4):e0125697. PubMed ID: 25919028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CXCL16/CXCR6 Axis Drives Microglia/Macrophages Phenotype in Physiological Conditions and Plays a Crucial Role in Glioma.
    Lepore F; D'Alessandro G; Antonangeli F; Santoro A; Esposito V; Limatola C; Trettel F
    Front Immunol; 2018; 9():2750. PubMed ID: 30542347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of chemokine receptor CXCR4 in malignant glioma cells promotes the production of vascular endothelial growth factor.
    Yang SX; Chen JH; Jiang XF; Wang QL; Chen ZQ; Zhao W; Feng YH; Xin R; Shi JQ; Bian XW
    Biochem Biophys Res Commun; 2005 Sep; 335(2):523-8. PubMed ID: 16084492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrophage migration inhibitory factor downregulation: a novel mechanism of resistance to anti-angiogenic therapy.
    Castro BA; Flanigan P; Jahangiri A; Hoffman D; Chen W; Kuang R; De Lay M; Yagnik G; Wagner JR; Mascharak S; Sidorov M; Shrivastav S; Kohanbash G; Okada H; Aghi MK
    Oncogene; 2017 Jun; 36(26):3749-3759. PubMed ID: 28218903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glioma stem cells-derived exosomes promote the angiogenic ability of endothelial cells through miR-21/VEGF signal.
    Sun X; Ma X; Wang J; Zhao Y; Wang Y; Bihl JC; Chen Y; Jiang C
    Oncotarget; 2017 May; 8(22):36137-36148. PubMed ID: 28410224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphatase and tensin homolog reconstruction and vascular endothelial growth factor knockdown synergistically inhibit the growth of glioblastoma.
    Chen H; Shen X; Guo C; Zhu H; Zhou L; Zhu Y; Wang H; Zheng Y; Huang L
    Cancer Biother Radiopharm; 2010 Dec; 25(6):713-21. PubMed ID: 21204766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predominance of M2 macrophages in gliomas leads to the suppression of local and systemic immunity.
    Vidyarthi A; Agnihotri T; Khan N; Singh S; Tewari MK; Radotra BD; Chatterjee D; Agrewala JN
    Cancer Immunol Immunother; 2019 Dec; 68(12):1995-2004. PubMed ID: 31690954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.